JP Lynch, EA Kazerooni, SE Gay - Clinics in chest medicine, 1997 - Elsevier Chronic pulmonary sarcoidosis may persist for years, resulting in inexorable
loss of lung function and destruction of the alveolar architecture. 71 , 132 ,
158 , 164 , 182 and 196 In that context, chest radiographs demonstrate ... Cited by 158 - Related articles - BL Direct - All 9 versions
- ►chestpubs.org JP Utz, AH Limper, S Kalra, U Specks, JP … - Chest, 2003 - chestjournal.chestpubs.org Background: Tumor necrosis factor (TNF)-α is produced by macrophages and other
cells, and is believed to participate in granulomatous inflammation. Targeted
antagonism of TNF-α has been proposed as a novel treatment strategy for ... Cited by 139 - Related articles - BL Direct - All 5 versions
JD Doty, JE Mazur, MA Judson - Chest, 2005 - chestjournal.chestpubs.org Results: Ten patients receiving infliximab were reviewed. Nine of the 10
patients reported a symptomatic improvement with therapy, and all 10
demonstrated objective evidence of improvement. A drug reaction developed ... Cited by 100 - Related articles - All 5 versions
- ►duanessolution.com S Biester, C Deuter, H Michels, R Haefner, … - British Journal of Ophthalmology, 2007 - bjo.bmj.com Methods: We retrospectively analysed 18 patients, who were treated with
Adalimumab (20–40 mg, every 2 weeks, when ineffective every week); 17 had
juvenile idiopathic arthritis, one was without detectable underlying ... Cited by 76 - Related articles - BL Direct - All 5 versions
I Storch, D Sachar, S Katz… - Inflammatory Bowel Diseases, 2003 - interscience.wiley.com Extraintestinal manifestations of both Crohn's disease and ulcerative colitis
(UC) have been well described, although pulmonary findings are often overlooked.
We summarize the experience of more than 400 cases of pulmonary ... Cited by 72 - Related articles - BL Direct - All 4 versions
- ►chestpubs.org SD Roberts, DS Wilkes, RA Burgett, KS Knox - Chest, 2003 - chestjournal.chestpubs.org Despite aggressive treatment with conventional therapy, sarcoidosis may be
progressive and debilitating. Tumor necrosis factor (TNF)-α is critical in the
genesis and maintenance of granulomatous inflammation. Agents developed to ... Cited by 69 - Related articles - BL Direct - All 5 versions
JC Shanahan, EW St. Clair - Clinical Immunology, 2002 - Elsevier Overproduction of tumor necrosis factor-α (TNF) plays a key role in the
pathogenesis of rheumatoid arthritis (RA) and other chronic inflammatory
diseases. In RA, excessive production of TNF-α can drive synovial ... Cited by 65 - Related articles - BL Direct - All 3 versions
JA Pettersen, DW Zochodne, RB Bell, L Martin … - Neurology, 2002 - AAN Enterprises 2002;59;1660 Neurology JA Pettersen, DW Zochodne, RB Bell, L. Martin and MD Hill
Refractory neurosarcoidosis responding to infliximab ... This information is
current as of October 15, 2009 ... All rights reserved. Print ISSN: ... Cited by 60 - Related articles - BL Direct - All 4 versions
D Khanna, MR Liebling, JS Louie - The Journal of Rheumatology, 2003 - jrheum.org From the Division of Rheumatology, Department of Medicine, UCLA Center for the
Health Sciences, Los Angeles; and Harbor–UCLA Medical Center, Torrance,
California, USA. D. Khanna, MD, Instructor, UCLA School of Medicine, Center ... Cited by 57 - Related articles - BL Direct - All 9 versions
H Nunes, P Soler, D Valeyre… - Allergy, 2005 - interscience.wiley.com Sarcoidosis is a multisystemic disease of unknown aetiology characterized by the
formation of immune granulomas in involved organs. It is a worldwide disease
that mainly affects 25–40 years old people with a lifetime incidence rate ... Cited by 52 - Related articles - All 4 versions
